Pascale Chavis

Dr. Pascale Chavis

Institut de Neurobiologiede la Méditerranée, Marseille, France
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in Nature
Verified
Journal Article
Closed access
PCPascale Chavis
Pascale Chavis
GWGary Westbrook
Gary Westbrook

22 August 1996 in Nature
Verified
Journal Article
Closed access
PDF file
PCPascale Chavis
Pascale Chavis
LFL. Fagni
L. Fagni
JLJeffry Lansman
Jeffry Lansman
JBJ. Bockaert
J. Bockaert

1 February 2000 in Trends in Neurosciences
Verified
Journal Article
Closed access
LFLaurent Fagni
Laurent Fagni
PCPascale Chavis
Pascale Chavis
FAFabrice Ango
Fabrice Ango
JBJoel Bockaert
Joel Bockaert

19 September 2007 in The Journal of Neuroscience
Verified
Journal Article
Open access
LGLaurent Groc
Laurent Groc
DCDaniel Choquet
Daniel Choquet
FSF. Anne Stephenson
F. Anne Stephenson
DVDanièle Verrier
Danièle Verrier
OMOlivier Jacques José Manzoni
Olivier Jacques José Manzoni
PCPascale Chavis
Pascale Chavis
During postnatal development, changes in the subunit composition of glutamate receptors of the NMDA subtype (NMDARs) are key to the refinement of excitatory synapses. Hypotheses for maturation of synaptic NMDARs include regulation of their expression levels, membrane targeting, and surface movements. In addition, several members of extracellular matrix (ECM) proteins such as Reelin are involved in synaptic plasticity. However, it is not known whether and how ECM proteins regulate synaptic NMDAR maturation. To probe the participation of NMDARs to synaptic currents and NMDARs surface dynamics, we used electrophysiological recordings and single-particle tracking in cultured hippocampal neurons. Our results show that, during maturation, Reelin orchestrates the regulation of subunit composition of synaptic NMDARs and controls the surface mobility of NR2B subunits. During postnatal maturation, we observed a marked decrease of NR1/NR2B receptor participation to NMDAR-mediated synaptic currents concomitant with the accumulation of Reelin at active synapses. Blockade of the function of Reelin prevented the maturation-dependent reduction in NR1/NR2B-mediated synaptic currents. The reduction of NR1/NR2B receptors was not inhibited by blocking synaptic activity but required β1-containing integrin receptors. Single-particle tracking showed that inhibition of Reelin decreased the surface mobility of native NR2B-containing NMDARs, whereas their synaptic dwell time increased. Conversely, recombinant Reelin dramatically reduced NR2B-mediated synaptic currents and the time spent by NR2B subunits within synapses. Our data reveal a new mode of control of synaptic NMDAR assembly at postnatal hippocampal synapses and an unprecedented role of ECM proteins in regulating glutamate receptor surface diffusion.

15 August 2011 in Learning & Memory
Verified
Journal Article
Closed access
PDF file
JRJustin T. Rogers
Justin T. Rogers
IRIan Rusiana
Ian Rusiana
JTJustin Trotter
Justin Trotter
LZLisa Zhao
Lisa Zhao
EDErika Donaldson
Erika Donaldson
EWEdwin J. Weeber
Edwin J. Weeber
Apolipoprotein receptors belong to an evolutionarily conserved surface receptor family that has intimate roles in the modulation of synaptic plasticity and is necessary for proper hippocampal-dependent memory formation. The known lipoprotein receptor ligand Reelin is important for normal synaptic plasticity, dendritic morphology, and cognitive function; however, the in vivo effect of enhanced Reelin signaling on cognitive function and synaptic plasticity in wild-type mice is unknown. The present studies test the hypothesis that in vivo enhancement of Reelin signaling can alter synaptic plasticity and ultimately influence processes of learning and memory. Purified recombinant Reelin was injected bilaterally into the ventricles of wild-type mice. We demonstrate that a single in vivo injection of Reelin increased activation of adaptor protein Disabled-1 and cAMP-response element binding protein after 15 min. These changes correlated with increased dendritic spine density, increased hippocampal CA1 long-term potentiation (LTP), and enhanced performance in associative and spatial learning and memory. The present study suggests that an acute elevation of in vivo Reelin can have long-term effects on synaptic function and cognitive ability in wild-type mice.

11 June 2013 in Molecular Psychiatry
Verified
Journal Article
Open access
JIJ Iafrati
J Iafrati
MOM J Orejarena
M J Orejarena
OLO Lassalle
O Lassalle
LBL Bouamrane
L Bouamrane
PCPascale Chavis
Pascale Chavis
Defective brain extracellular matrix (ECM) is a factor of vulnerability in various psychiatric diseases such as schizophrenia, depression and autism. The glycoprotein reelin is an essential building block of the brain ECM that modulates neuronal development and participates to the functions of adult central synapses. The reelin gene (RELN) is a strong candidate in psychiatric diseases of early onset, but its synaptic and behavioral functions in juvenile brain circuits remain unresolved. Here, we found that in juvenile reelin-haploinsufficient heterozygous reeler mice (HRM), abnormal fear memory erasure is concomitant to reduced dendritic spine density and anomalous long-term potentiation in the prefrontal cortex. In juvenile HRM, a single in vivo injection with ketamine or Ro25-6981 to inhibit GluN2B-N-methyl-D-aspartate receptors (NMDARs) restored normal spine density, synaptic plasticity and converted fear memory to an erasure-resilient state typical of adult rodents. The functional and behavioral rescue by ketamine was prevented by rapamycin, an inhibitor of the mammalian target of rapamycin pathway. Finally, we show that fear memory erasure persists until adolescence in HRM and that a single exposure to ketamine during the juvenile period reinstates normal fear memory in adolescent mice. Our results show that reelin is essential for successful structural, functional and behavioral development of juvenile prefrontal circuits and that this developmental period provides a critical window for therapeutic rehabilitation with GluN2B-NMDAR antagonists.